The accumulation of dicarboxylic acids, particularly long chain, is a prominent feature of Reye's syndrome and diseases of peroxisomal metabolism. We assessed the omega-oxidation of a spectrum of fatty acids in rats and asked whether pretreatment ofrats with aspirin, which is known to predispose children to Reye's syndrome, would affect omega-oxidation of long chain fatty acids. We found that aspirin increased liver free fatty acids and increased the capacity for omega-oxidation three-to sevenfold. Omega-oxidation of long chain substrate was stimulated to a greater degree than medium chain substrate and was apparent within one day of treatment, at serum aspirin concentrations below the therapeutic range in humans. The apparent Km for lauric acid was 0.9 ,1M and 12 gM for palmitate.
taglandins, leukotrienes, drugs, and carcinogens (3) . However, while these other P-450 systems have been extensively studied, little is known about the control of the formation ofdicarboxylic acids or about their role in mammalian fatty acid metabolism. Both the omega-and omega-l pathways are reported to function in liver, kidney, lung, colon, and polymorphonuclear leukocytes (4) (5) (6) (7) . Fatty acid omega-and omega-l-hydroxylation can be induced in experimental animals with starvation or ketosis as well as by phenobarbital, clofibrate, di(2-ethylhexyl)-phthalate and acetylsalicylic acid (8) (9) (10) (11) (12) (13) . Induction of omegaoxidation in starved or ketotic rats indicates that in vivo, no more than 5% of free fatty acids are oxidized by this pathway (14) . However, it has recently become apparent that the accumulation of dicarboxylic acids features prominently in several disease states in humans.
In Reye's syndrome dicarboxylic acids constitute as much as 55% of the total serum free fatty acids (15) . In this illness 85-90% of the dicarboxylic acids are long chain, 16 or 18 carbon chain lengths, which have been reported only in Reye's syndrome and in patients with inborn errors of peroxisomal metabolism (16) . Administration of long chain dicarboxylic acids is lethal (17) . Long chain dicarboxylic acids induce swelling of mitochondria, uncouple oxidative phosphorylation and inhibit ATP formation (18) (19) (20) . Because a generalized impairment of mitochondrial function is central to the pathogenesis of Reye's syndrome (21) and alterations in mitochondria are observed in some peroxisomal diseases (22, 23) these observations suggest that dicarboxylic acids, particularly long chain dicarboxylic acids, could play a role in the pathophysiology of these illnesses.
Investigations of omega-hydroxylation have demonstrated activity toward a variety of monocarboxylic acid substrates; however, experiments have mainly focused on the omega-hydroxylation oflauric acid (24) . Low concentrations ofmedium chain dicarboxylic acids appear to be a frequent and nonspecific finding in a variety ofconditions in humans (25) . Medium chain length dicarboxylic acids are present as food additives and have little toxicity in vitro or in vivo (17) (18) (19) 26) . To understand dicarboxylic acid formation in disease states such as Reye's syndrome, we assessed the omega-oxidation of a spectrum offatty acids including long chain compounds in rats. We also asked whether pretreatment of rats with aspirin, which is known to predispose children to Reye's syndrome (27) , would affect the omega-oxidation of long chain fatty acids. In this study we have shown that acetylsalicylic acid treatment of rats substantially increases the capacity for long chain dicarboxylic acid formation. [5, 6, 8, 9 ,1 1,12,14,15-3H]arachidonic acid were purchased from Amersham Corp., (Arlington Heights, IL). Pentane (99%+, spectrophotometric grade) was from Aldrich Chemical Co. (Milwaukee, WI). Diethyl ether (analytical grade) was purchased from J. T. Baker Co. (Phillipsburg, NJ). All other solvents used were of HPLC grade.
Animals. Male Sprague-Dawley rats (80-120 g) were purchased from Sasco (Madison, WI). Rats were fed standard rodent chow for 10 d while being acclimated. Experimental animals were then fed rodent chow supplemented with 1% (wt/wt) acetylsalicylic acid. The chow was prepared by Ralston Purina (Richmond, IN) by adding crystalline acetylsalicylic acid to dry rodent chow, after which the mixture is formed into pellets. The percentage of acetylsalicylic acid supplementation chosen for this study was determined from previous observations on the effect of acetylsalicylic acid on rat liver metabolism and ultrastructure (13, 28, 29) . In one series of experiments, the amount of chow consumed by the animals was determined, enabling us to calculate the amount ofsalicylate given to the rats. Control animals were fed normal rodent chow. Animals were fasted overnight before sacrifice and harvesting the liver. Serum salicylate levels were measured in nonfasting animals using the method of Mays et al. (30) .
Subcellularfractionation. Livers were washed with homogenization buffer containing 0.1 M Tris-HCI, 0.0048 M MgCI2, and 0.03 M nicotinamide (pH 9.5), minced and homogenized in 20% (wt/wt) buffer in a Potter-Elvehjem homogenizer with a Teflon pestle. The homogenate was centrifuged at 800 g for 10 min to remove the cell debris and nuclei, followed by centrifugation at 20,000 g for 10 min to remove the mitochondria. This postmitochondrial supernatant fraction was stored at -20'C until used. Alternatively, liver homogenate was fractionated according to the method of DeDuve et al. (31) with the modifications suggested by Ghosh and Hajra (32) .
Assessment ofomega-oxidation. In most experiments omega-oxidation was assessed by the method ofPreiss and Bloch using the 20,000 g liver supernatant fraction (33) . The assay mixture contained 8 mM sodium phosphate (pH 8.0), 1.8 mM MgCI2 2 mM B-NADPH, 1.2 mM B-NAD, 0.03 M nicotinamide and between 2 and 30 mg ofprotein in a total volume of 5 ml. Omega-oxidative capacity was initially assessed with 200MM potassium salt of'4C-or 3H-labeled monocarboxylic acid as substrate and 30 mg of protein incubated for 1 h in a shaking water bath at 37°C as described by Preiss and Bloch (33) . This concentration of substrate facilitated analysis of the products by gas chromatography and thin layer chromatography. The results of experiments using the substrates laurate, palmitate, palmitoleate, stearate, oleate, and arachidonate were confirmed using 2 MM radiolabeled substrate and 2 mg protein in a volume of 5 ml incubated for 10 min. Results of experiments using the substrates undecanoate, tridecanoate, myristate, pentadecanoate, and hepadecanoate were confirmed using 2 MM unlabeled substrate and 10 mg ofprotein in a total volume of25 ml. Experiments examining the subcellular localization ofomega-oxidation were all performed using 2 (3-70% ether in pentane). The fraction size was 1.0 ml. Fractions were monitored for radioactivity, and the products analyzed by gas chromatography or gas chromatography coupled with mass spectrometry. Monocarboxylic acids elute with 4-5% ether in pentane, dicarboxylic acids elute with 1 1-15% ether, and more polar products (ketoacids and ketodicarboxylic acids) elute at ether concentrations exceeding 20%.
Gas chromatography was performed using a model 5890A gas-liquid chromatograph (Hewlett-Packard Co., Palo Alto, CA) with a 15m, 0.53-mm inner diam, 2.0-M, fused silica glass capillary column (liquid phase methyl 5% phenyl silicone) as described previously (15) .
Monocarboxylic and dicarboxylic acids were identified by comparison of the retention times with authentic standards and by mass spectroscopy.
The quantitation of the products of omega-oxidation was done in two ways: First, a known amount of pentadecanoic acid was added to pooled fractions from the silicic acid column. The fractions were then derivatized and analyzed by gas chromatography (15) . The amount of the monocarboxylic and dicarboxylic acids was determined from the peak area divided by the area ofthe pentadecanoic acid peak multiplied by the previously determined response factor (micrograms monocarboxylic or dicarboxylic acid per microgram of pentadecanoic acid) for each compound times the molecular weight and adjusted for the extraction efficiency as determined by the recovery of radioactive counts. In some cases, the amount of product was determined from the eluent radioactivity in different fractions multiplied by the specific activity of the monocarboxylic acid substrate. These two methods were compared and gave consistent and similar results.
To identify the proportion of reaction products from endogenous substrate and radiolabeled substrate, we analyzed fractions by gas chromatography and thin layer chromatography using KCG8 reverse phase plates with a preabsorbent layer (Whatman Chemical Separation, Inc., Clifton, NJ). The compounds were separated in acetonitrile:acetic acid:water (70:10:25) or methanol:acetic acid:formic acid (80:10:10). Radiolabeled authentic dicarboxylic acids were used as standards. The radioactive products were identified after exposing the TLC plates to Kodak XAR film at -70'C. The bands were quantitated by densitometry using a Hoefer gel scanner. The results of different dilutions were compared and averaged.
Free fatty acids were measured in the postmitochondrial supernatant according to the method of Novak (35) .
Enzyme assays. Subcellular fractionation was monitored using the following marker enzymes: succinic dehydrogenase as measured by Moore (36) and Pennington (37) , catalase as determined by Cohen et al. (38) glucose-6-phosphatase as described by Ricketts (39) and betahexosaminidase as described by Kolodny and Mumford (40) . Protein was estimated using the method of Lowry et al. (41) . In the case of subcellular fractions containing Nycodenz or Percoll, the fractions were dialyzed for 36 h against several changes of PBS and then the protein was estimated using the method ofLowry et al. (41) after precipitating the protein with 2% deoxycholate and 24% TCA as described by Ghosh and Hajra (32) .
Statistical analysis. Results are expressed as mean±SD. Separation between groups was analyzed using the Student t test. Unless indicated otherwise, the points in the figures are the experimental observations. In Figs. 2 and 3 the line represents the best fit of the data using a statistical computer program.
Results
Omega-oxidation in normal rat liver homogenate. The omegaoxidation of a spectrum of monocarboxylic acids in the postmitochondrial supernatant fraction of homogenized rat liver was examined. In animals fed a normal diet, omega-oxidation of endogenous substrate is limited (1.27±0.97 nmol of dicarboxylic acid formed/h per mg protein in the absence of substrate, n = 5). No dicarboxylic acid is formed in the absence of cofactors NADPH, NAD, and nicotinamide. With the addition of200 ,uM monocarboxylic acid (C12-C20:4), 0.6-6.5 nmol of the corresponding dicarboxylic acid are formed/h per mg, depending on the substrate (Table I ). The predominant product is dicarboxylic acid but a small amount (0.10-0.43 nmol/h per mg) of omega-1 -ketoacids are also formed. As previously reported (2, 42, 43), we found the formation ofdicarboxylic acids is maximal with 1 mM NADPH, 0.5 mM NAD, and 0.03 M nicotinamide (data not shown). Monocarboxylic acids of 12-15 carbon lengths are preferred substrates for omega-oxidation (Table I) . Acetylsalicylic acid increases the capacityfor omega-oxidation. With the addition of acetylsalicylic acid (1% wt/wt) to the diet, liver weight increases (Table II) and omega-oxidation is stimulated (Table I ). The omega-oxidation of lauric acid increases after 1 d of treatment with acetylsalicylic acid (Fig. 1) . Near maximal stimulation of omega-oxidation of lauric acid occurs after 4 d of treatment (15.3±0.8 nmol of dicarboxylic acid/h per mg protein, n = 2, compared to 3.8±1.2 nmol of dicarboxylic acid/h per mg protein, n = 9, without treatment with acetylsalicylic acid). This stimulation occurs at a serum salicylate level of 12 mg/dl (Table II) which is well below the (Fig. 1) . Acetylsalicylic acid also stimulates the oxidation of long chain substrate (Table I, Fig. 1 ). As in the case of the omega-oxidation of lauric acid, stimulation of the omega-oxidation of palmitic acid is apparent after 4 d. However, treatment with acetylsalicylic acid for 2 wk results in an additional 57% increase in the capacity to oxidize palmitate (Fig. 1) . After 2 wk ofacetylsalicylic acid, the formation of dodecanedioic acid increases more than fourfold and the formation ofhexadecanedioic acid increases more than sixfold (Table I) . Similarly the formation of octadecanedioic acid increases more than sevenfold (Table I) . However, the increase in omega-oxidation of arachidonate is only threefold ( Table I) . Characterization of the omega-oxidation of medium and long chain substrate. To compare the omega-oxidation of medium (Cl 1-C 14) and long (C16-C18) chain substrate in acetylsalicylic acid treated animals, we examined the effect of enzyme concentration, incubation time, and substrate concentration on the formation of medium and long chain dicarboxylic acids. The formation of dodecanedioic acid is linear over a protein concentration of 0.5-3.0 mg, and with incubation times up to 15 min (Fig. 2) . The formation ofhexadecanedioic acid was found to be linear over the same protein concentration range and time interval (data not shown). The omega-oxidation of laurate was linear with a substrate concentration of 0-2 ,uM, whereas the omega-oxidation of palmitic acid was linear over a substrate concentration of 0-5 sM (Fig. 3) . The apparent Km for the formation of dodecanedioic and hexadecanedioic acids was determined using the direct linear plot of Eisenthal and Cornish-Bowden (44) . The apparent Km of the omega-oxidation oflaurate is 0.9 ,uM, whereas the apparent Km that in addition to dodecanedioic acid, dicarboxylic acids of 14-20 carbon chain lengths are also formed (Table III) (Fig. 4) . Is the same enzyme(s) responsiblefor the omega-oxidation ofmedium and long chain substrate? Analysis of the products of incubations with [1 -I4C] Figure 4 . The effect of storage on the capacity for omega-oxidation of medium and long chain substrate. Omega-oxidation was assessed as described in Fig. 3 The products of omega-oxidation of medium and long chain substrate. Reactions were performed as described in Table I This indicates that the majority of the dicarboxylic acid products in the stearate incubations and 20% of the dicarboxylic acid products in laurate incubations were formed from endogenous substrate and suggests that treatment with acetylsalicylic acid either stimulates the capacity for omega-oxidation of endogenous substrate or increases the endogenous free fatty acid pool. Experiments using 2 MM radiolabeled substrate demonstrated an identical spectrum of unlabeled compounds, indicating that the substrate was not releasing membrane bound fatty acids via a detergentlike effect. When omega-oxidation is assessed using postmitochondrial supernatant from control animals in the presence of NADPH, NAD, and nicotinamide but in the absence ofexogenous substrate, 1.3±1.0 nmol of dicarboxylic acid/h per mg protein are formed (n = 5); in contrast, 6.3±2.5 nmol ofdicarboxylic acid/h per mg are formed (n = 5) in the absence of exogenous substrate when liver homogenate from rats treated with acetylsalicylic acid is used. The free fatty acid concentration in postmitochondrial supernatant from animals fed a normal diet is 0.26 mEq/liter compared to 0.65 mEq/liter in the postmitochondrial supernatant from rats treated with acetylsalicylic acid. Thus, there is a significant increase in free fatty acids with acetylsalicylic acid treatment; however, the total amount ofomega-oxidation increases as well. The total omegaoxidation of laurate in 33.8 g of liver homogenate from seven normal rats was 21.2 nmol/h compared to 41.22 nmol/h in Induction ofOmega-Oxidation 1869 1 
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43.8 g of liver homogenate from six rats treated with acetylsalicylic acid for 2 wk. Subcellular localization. To determine whether the activity for the omega-oxidation ofmedium and long chain substrate is present in the same subcellular compartments, we examined subcellular fractions of liver from rats treated with acetylsalicylic acid and from rats fed a normal diet. Previous studies have focused on microsomes as the site of lauric acid omegahydroxylase (8, 24, 45) . We found that 97% ofthe total laurate omega-oxidative activity recovered was present in the microsomal fraction (Fig. 6) . In contrast, only 62.5% of the total palmitate omega-oxidative activity was present in the microsomes even though 94% of the total glucose-6-phosphatase activity, a microsomal marker enzyme, was recovered in the microsomal fraction. 32% ofthe palmitate omega-oxidative activity was present in the cytosol and 4% in the mitochondrial fraction. The distribution ofomega-oxidation ofpalmitate and laurate in normal and acetylsalicylic acid treated rats was not significantly different. Discussion We undertook the current studies to determine whether treatment with acetylsalicylic acid could contribute to the profound dicarboxylic acidemia, particularly the long chain dicarboxylic acidemia, seen in Reye's syndrome (15) . Our studies confirm and extend the observation of Okita that acetylsalicylic acid stimulates lauric acid omega-hydroxylation (13) . Acetylsalicylic acid stimulates the omega-oxidation of a wide spectrum of monocarboxylic acids. This stimulation occurs within a day of treatment and at plasma salicylate concentrations that are below the therapeutic range in humans.
Although the amount of acetylsalicylic acid added to the diet was substantial, previous investigators have demonstrated that 1% supplementation induces biochemical and morphologic changes in rat liver without apparent toxicity (13, 28, 29) . The amount of salicylate administered to the rats each day (600-700 mg/kg) was comparable to the dose of acetylsalicylic acid (450-600 mg/kg) which Smith et al. (46) observed to an have antipyretic effect in rats and is substantially below the oral LD50 for acetylsalicylic acid (1,500 mg/kg) in rats (47). The experiments establishing both a therapeutic dose and an LDso are not strictly comparable to our experiments with chow supplemented with acetylsalicylic acid, because Eagle and Carlson (47) and Smith et al. (46) used a single dose ofcrystalline acetylsalicylic acid in fasting animals. The salicylate levels indicate that the concentration ofsalicylate achieved in the blood ofour rats was either below or at the very lower limit ofthe therapeutic level in humans. Our observations as well as others indicate that only a fraction of acetylsalicylic acid is absorbed in rats (46, 47) .
We have demonstrated that the increase in omega-oxidation induced by acetylsalicylic acid is not limited to medium chain length substrate but also includes longer chain substrates (C16-C20). Although there is some variability in the degree of (Table III) . The difference between the stimulation of omega-oxidation of laurate and longer chain compounds is particularly noteworthy because medium chain length compounds (Cl 1-C15) are the preferred substrates in untreated animals (Table I ). These observations and the prominence of dicarboxylic acids of 16-18 carbon lengths in disease states led us to speculate that there might be separate enzymes for the omega-oxidation of different chain length substrates.
The studies reported herein support that possibility. First, induction oflauric acid omega-oxidation is maximal within 4 d oftreatment, whereas palmitate omega-oxidation peaks after 2 wk. Second, activity for the omega-oxidation of palmitate declines by 95% after 3 wk of storage, whereas activity toward medium chain substrate does not decline as profoundly. In addition, the apparent Km for laurate and palmitate differ by more than an order of magnitude. Competition experiments with laurate and palmitate demonstrate that saturating concentrations of palmitate have no effect on the omega-oxidation of laurate; conversely, saturating concentrations of laurate decrease but never eliminate the omega-oxidation of palmitate. We found a similar lack of competition between laurate and the other long chain substrates, palmitoleate, heptadecanoate, stearate, and oleate. Finally, in animals treated with acetylsalicylic acid, the subcellular distribution of laurate and palmitate omega-oxidative activity differs. Thus, these experiments strongly suggest that there may be separate enzymes for the omega-oxidation of laurate and fatty acids of 16-18 carbon lengths with overlapping substrate specificity. These observations indicate that the omega-oxidation of monocarboxylic acids may be analagous to beta-oxidation of monocarboxylic acids in which there are multiple enzymes with different but overlapping chain length specificity (48) .
Previous investigators have demonstrated multiple isoforms with fatty acid omega-hydroxylase activity in rat liver (24, 49, 50) . The function ofthese isoforms is unknown. Before these studies, Bjorkhem and Hamberg suggested the presence of different isoforms of omega-I -dehydrogenase activity in microsomes and supernatant on the basis of different cofactor requirements (2) . In addition, investigators have postulated multiple P-450 fatty acid hydroxylase isoforms on the basis of differential effects of various drugs and suicide substrates on omega-and omega-1-hydroxylation (8, 51, 52) . Wada et al.
demonstrated that aminopyrine, aniline, and ethylisocyanide have differential effects on the omega-oxidation ofstearate and laurate (51) . They were the first investigators to suggest that there might be P-450 isoforms for medium and long chain substrate in rat liver. More recently, Boddupalli et al. have demonstrated a P-450 enzyme in bacteria which appears to preferentially omega-hydroxylate long chain substrate (53) . Our investigations provide additional support for the possibility that the P-450 omega-hydroxylase isoforms may have different chain length specificities in rats.
We examined the subcellular distribution of omega-oxidation to evaluate the possibility that medium and long chain omega-oxidation are localized in different subcellular compartments. The finding of dicarboxylic acid accumulation in peroxisomal diseases also influenced us to perform this part of the study. Our results demonstrate a significant difference in the distribution of omega-oxidative activity for medium and long chain substrate. One-third of omega-oxidative activity for palmitate is present in the cytosol of animals treated with acetylsalicylic acid. In contrast, 97% of laurate omega-oxidative activity and 94% of the microsomal marker enzyme activity was recovered in the microsomal fraction. Treatment with acetylsalicylic acid also significantly increases the hepatic pool of free fatty acids. The mechanism of this increase is unclear. The increase in free fatty acids could be due to the activation of endogenous phospholipase activity which has been postulated previously in Reye's syndrome (54) .
Finally, our results may provide some insight into the potential effects ofacetylsalicylic acid in humans and particularly patients with Reye's syndrome. Treatment with acetylsalicylic acid predisposes patients to Reye's syndrome. In one study, exposure to acetylsalicylic acid was demonstrated in 95% of patients (27) . However, frequently the exposure to this medication is transient so that many patients present with low or undetectable salicylate levels (55). These findings suggest that acetylsalicylic acid is more likely to induce a pathologic process in susceptible individuals rather than to have direct toxic effects on mitochondrial function.
Reye's syndrome is characterized by massive fatty infiltration of the viscera and a profound free fatty acidemia with modest or low plasma ketones. As much as 55% of the serumfree fatty acids are long chain dicarboxylic acids (15) . Long chain dicarboxylic acids are characteristic of Reye's syndrome as well as disorders of peroxisomal metabolism.
Our results indicate that acetylsalicylic acid is a very potent stimulator of dicarboxylic acid formation, particularly long chain dicarboxylic acid formation, and that this stimulation is apparent after a single day of acetylsalicylic acid and with low concentrations of plasma salicylates. Moreover, our results demonstrate that treatment with acetylsalicylic acid could contribute to the increased free fatty acid pool in these patients, thereby further stimulating long chain dicarboxylic acid formation. Because dicarboxylic acids are potentially toxic to cellular function (17) (18) (19) (20) , delineation ofthe factors which influence the formation and metabolism of dicarboxylic acids could be important in understanding the pathologic processes in disease states such as Reye's syndrome and inborn errors of peroxisomal and mitochondrial fatty acid metabolism and could also contribute to our understanding of the potentially toxic effects of acetylsalicylic acid, which is widely consumed on a chronic basis, on lipid metabolism.
